Per-Göran Gillberg
Director/Board Member at ALZINOVA AB
Per-Göran Gillberg active positions
| Companies | Position | Start | End |
|---|---|---|---|
| ALZINOVA AB | Director/Board Member | 2019-12-31 | - |
| Independent Dir/Board Member | 2019-12-31 | - | |
| DICOT PHARMA AB | Director/Board Member | 2021-05-26 | - |
| Independent Dir/Board Member | 2021-05-26 | - | |
Albireo AB
 Albireo AB Pharmaceuticals: MajorHealth Technology Albireo AB operates as a biopharmaceutical company, which focuses on the development and potential commercialization of novel bile acid modulators. It helps treat orphan pediatric liver diseases and gastrointestinal disorders where the improper flow or absorption of bile causes serious medical conditions for which there is high unmet need. The company was founded by Per-Göran Gillberg and Jan Mattsson and is headquartered in Göteborg, Sweden. | Founder | 1997-12-31 | - |
| Corporate Officer/Principal | 1997-12-31 | - |
Career history of Per-Göran Gillberg
Former positions of Per-Göran Gillberg
| Companies | Position | Start | End |
|---|---|---|---|
| ALBIREO PHARMA, INC. | Corporate Officer/Principal | - | - |
| ALBIREO PHARMA, INC. | Founder | 2003-12-07 | - |
| Corporate Officer/Principal | 2003-12-07 | - | |
| Karolinska Institutet | Director/Board Member | - | - |
| Pharmacia AB | Corporate Officer/Principal | - | - |
| Pharmacia & Upjohn, Inc. | Corporate Officer/Principal | - | - |
| KABI-AM | Corporate Officer/Principal | - | - |
| ░░░░░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
| ░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | - |
Training of Per-Göran Gillberg
| University of Uppsala | Doctorate Degree |
Statistics
International
| Sweden | 7 |
| United States | 4 |
| United Kingdom | 3 |
Operational
| Corporate Officer/Principal | 8 |
| Director/Board Member | 3 |
| Founder | 2 |
Sectoral
| Health Technology | 9 |
| Consumer Services | 4 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 3 |
|---|---|
| ASTRAZENECA PLC | Health Technology |
| ALZINOVA AB | Health Technology |
| DICOT PHARMA AB | Health Technology |
| Private companies | 6 |
|---|---|
Albireo Ltd.
 Albireo Ltd. Pharmaceuticals: MajorHealth Technology Albireo Ltd. develops therapies that address medical needs in the gastrointestinal and liver disease area. It is a biotechnology company that develops therapies that address unmet medical needs in the gastrointestinal area and liver disease area. The firm's programs include Cholestatic Liver Diseases; Bile Acid Mal-absorption; Type 2 Diabetes Mellitus; Atopic Dermatitis and Psoriasis; and Post-Operative Adhesions. The company was founded by Jan Peter Mattsson in February 2008 and is headquartered in London, the United Kingdom. | Health Technology |
| KABI-AM | Consumer Services |
| Pharmacia & Upjohn, Inc. | Health Technology |
| Pharmacia AB | Health Technology |
Albireo AB
Albireo AB Pharmaceuticals: MajorHealth Technology Albireo AB operates as a biopharmaceutical company, which focuses on the development and potential commercialization of novel bile acid modulators. It helps treat orphan pediatric liver diseases and gastrointestinal disorders where the improper flow or absorption of bile causes serious medical conditions for which there is high unmet need. The company was founded by Per-Göran Gillberg and Jan Mattsson and is headquartered in Göteborg, Sweden. | Health Technology |
Albireo Pharma, Inc.
 Albireo Pharma, Inc. Pharmaceuticals: MajorHealth Technology Albireo Pharma, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of novel bile acid modulators for the treatment of orphan pediatric liver diseases and gastrointestinal disorders. Its pipeline products include Odevixibat, A3384, and Elobixibat. The company was founded by Jan Peter Mattsson and Per-Göran Gillberg on December 8, 2003 and is headquartered in Boston, MA. | Health Technology |
- Stock Market
- Insiders
- Per-Göran Gillberg
- Experience
